Effect of fluphenazine HCl on R3230AC mammary carcinoma and mammary glands of the rat.
D000230:Adenocarcinoma / Q000188:drug therapy* / Q000201:enzymology; D000818:Animals; D001219:Aspartate Aminotransferases / Q000378:metabolism; D004273:DNA, Neoplasm; D005230:Fatty Acids, Nonesterified / Q000378:metabolism; D005260:Female; D005476:Fluphenazine / Q000627:therapeutic use*; D005954:Glucosephosphate Dehydrogenase / Q000378:metabolism; D008291:Malate Dehydrogenase / Q000378:metabolism; D008321:Mammary Glands, Animal / Q000378:metabolism; D008325:Mammary Neoplasms, Experimental / Q000188:drug therapy*; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000201:enzymology; D010733:Phosphoglucomutase / Q000378:metabolism; D011388:Prolactin / Q000378:metabolism; D051381:Rats; D014184:Transplantation, Homologous; D014280:Triglycerides / Q000378:metabolism
D004273:DNA, Neoplasm; D005230:Fatty Acids, Nonesterified; D014280:Triglycerides; D011388:Prolactin; D008291:Malate Dehydrogenase; D005954:Glucosephosphate Dehydrogenase; D001219:Aspartate Aminotransferases; D010733:Phosphoglucomutase; D005476:Fluphenazine